Search Results
Baxter to Present at the 5th Annual Evercore ISI HealthCONx Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through May 30, 2023. About Baxter
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 3, 2023, to shareholders of record as of December 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter
'It's About the Patient & Purpose'
For Darren Evans, work is not simply a job, it's a career with a larger purpose. As vice president, Global Technical Services at Baxter, Darren's teams ensure our customers have the equipment and technology they need to serve their patients. We spoke with Darren, who joined Baxter as part of the company's recent acquisition of Hillrom, to learn about how he and his team support patients and customers on a daily basis.
Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays in increasing access to and quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022, Nov. 3-6, Orlando, Florida. Key data highlighted include:
A Journey to Home Care While Waiting for a Transplant
Amber went to see her doctor for what she thought was a prolonged stomach virus but quickly learned instead that her kidneys had failed and she required dialysis. Her unplanned start put her in a position of initiating dialysis without the benefit of therapy education about her choices and related lifestyle options. She learned to define her kidney journey with the help of her community, by asking questions and proactively managing her path to transplant.
Activating Our Passion to Increase Kidney Care Access
We spoke with Peter Rutherford, MB BS, PhD, FRCP, vice president of Worldwide Medical Affairs for our Renal Care business, about his experience as a practicing nephrologist and his quest to improve global access to kidney care and patient outcomes.
Finding a Comforting Connection Throughout Cancer Treatment Journey
Going through cancer treatment during the COVID-19 pandemic could have been a solitary experience for this packaging engineer. But the constant presence of the products that save and sustain lives let her know she had the entire Baxter team in her corner.
Baxter Reports Third-Quarter 2022 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2022.
Baxter Issues Urgent Medical Device Correction Regarding Potential Radio Frequency Interference With Other Devices Near Beds Installed With WatchCare System
Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the WatchCare Incontinence Management System due to potential for radio frequency (RF) interference with other medical devices. The WatchCare system is designed to discreetly alert the caregiver of an incontinence event.
Empowered to promote an inclusive culture | Empoderados para promover una cultura inclusiva I Empoderados para promover uma cultura inclusiva
Mi casa es tu casa. Everyone at Baxter is welcomed into the HOLA business resource group. This familia is represented all over the world; some may be Latinx; others may simply love the cultures, languages, customs and traditions. Together, HOLA forms a colorful spectrum of diverse cultures and professions.